Neuracle develops implantable brain-computer interface systems for research, clinical, and rehabilitation use in China. Its most visible medical product is NEO, a hand motor function compensation system for people with quadriplegia caused by cervical spinal cord injury. The product has moved into an approved commercial medical-device pathway in China.

NEO uses a minimally invasive extradural implant to acquire neural signals and decode motor intent. The decoded signals are translated into control commands for an external assistive glove, allowing users to perform hand grasp movements. This gives the system a focused functional-restoration profile around upper-limb motor assistance.

Neuracle targets patients with severe motor impairment through specialist clinical and rehabilitation settings. Its role on the map is as a clinically focused Chinese BCI company using a lower-tissue-penetration implant strategy for hand function restoration.